179.34
전일 마감가:
$182.45
열려 있는:
$182.48
하루 거래량:
451.35K
Relative Volume:
0.47
시가총액:
$13.69B
수익:
$8.19B
순이익/손실:
$758.19M
주가수익비율:
19.54
EPS:
9.18
순현금흐름:
$1.06B
1주 성능:
-3.51%
1개월 성능:
+14.60%
6개월 성능:
+26.42%
1년 성능:
-11.77%
Icon Plc Stock (ICLR) Company Profile
ICLR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ICLR
Icon Plc
|
179.34 | 13.93B | 8.19B | 758.19M | 1.06B | 9.18 |
|
TMO
Thermo Fisher Scientific Inc
|
562.56 | 214.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
222.63 | 158.72B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
695.60 | 55.35B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
136.66 | 39.40B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
221.43 | 37.75B | 15.90B | 1.28B | 2.21B | 7.2842 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-09-09 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-09-03 | 업그레이드 | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-07-24 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-04-14 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-04-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-03-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-01-07 | 개시 | RBC Capital Mkts | Outperform |
| 2024-10-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | 개시 | Redburn Atlantic | Neutral |
| 2024-09-18 | 개시 | Leerink Partners | Outperform |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2023-12-15 | 개시 | Truist | Buy |
| 2023-09-13 | 개시 | TD Cowen | Outperform |
| 2023-01-17 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-01-13 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-11-09 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-09-07 | 개시 | UBS | Buy |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-05-24 | 개시 | Guggenheim | Buy |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2021-09-27 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-23 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-14 | 개시 | Citigroup | Neutral |
| 2021-04-13 | 재개 | BofA Securities | Neutral |
| 2021-04-01 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | 개시 | Barclays | Equal Weight |
| 2021-03-01 | 업그레이드 | UBS | Neutral → Buy |
| 2021-02-26 | 업그레이드 | Truist | Hold → Buy |
| 2020-07-24 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-04-20 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-03-02 | 개시 | Deutsche Bank | Hold |
| 2020-01-27 | 다운그레이드 | SunTrust | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-09-23 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | 업그레이드 | UBS | Sell → Neutral |
| 2019-01-25 | 업그레이드 | Mizuho | Neutral → Buy |
| 2018-10-26 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-10-09 | 개시 | UBS | Sell |
| 2018-04-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2018-02-15 | 재확인 | Mizuho | Neutral |
| 2018-01-19 | 개시 | Evercore ISI | Outperform |
| 2017-10-27 | 재확인 | Barclays | Equal Weight |
| 2017-09-11 | 개시 | BofA/Merrill | Buy |
| 2017-07-31 | 업그레이드 | SunTrust | Hold → Buy |
| 2017-07-27 | 재확인 | Mizuho | Neutral |
| 2017-06-29 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
Icon Plc 주식(ICLR)의 최신 뉴스
Here’s Why ICON Plc. (ICLR) Gained +20.3% in Q3 - Insider Monkey
BofA Securities downgrades ICON stock rating to Neutral on 2026 growth concerns By Investing.com - Investing.com South Africa
BofA Securities downgrades ICON stock rating to Neutral on 2026 growth concerns - Investing.com UK
BofA Securities Downgrades Icon PLC(ICLR.US) to Hold Rating, Announces Target Price $195 - 富途牛牛
Barclays Maintains Icon PLC(ICLR.US) With Hold Rating, Raises Target Price to $200 - 富途牛牛
Icon Plc $ICLR Shares Bought by Liontrust Investment Partners LLP - MarketBeat
Lazard Asset Management LLC Sells 308,092 Shares of Icon Plc $ICLR - MarketBeat
Neuberger Berman Group LLC Sells 553,413 Shares of Icon Plc $ICLR - MarketBeat
193,000 Shares in Icon Plc $ICLR Purchased by Hudson Bay Capital Management LP - MarketBeat
Icon Plc $ICLR Shares Bought by Holocene Advisors LP - MarketBeat
75,000 Shares in Icon Plc $ICLR Bought by Hound Partners LLC - MarketBeat
Hudson Bay Capital Management LP Makes New $28.07 Million Investment in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Acquired by Headlands Technologies LLC - MarketBeat
Icon Plc $ICLR Shares Bought by The Manufacturers Life Insurance Company - MarketBeat
Bamco Inc. NY Lowers Position in Icon Plc $ICLR - MarketBeat
Boone Capital Management LLC Invests $13.94 Million in Icon Plc $ICLR - MarketBeat
Sei Investments Co. Acquires 309,635 Shares of Icon Plc $ICLR - MarketBeat
300,000 Shares in Icon Plc $ICLR Purchased by Camber Capital Management LP - MarketBeat
California Public Employees Retirement System Has $22.55 Million Stock Position in Icon Plc $ICLR - MarketBeat
Axa S.A. Cuts Stock Position in Icon Plc $ICLR - MarketBeat
Jefferies rates IQVIA, Charles River as Buy, ICON as Hold - MSN
Icon Plc $ICLR Shares Bought by Qube Research & Technologies Ltd - MarketBeat
Amundi Sells 7,228 Shares of Icon Plc $ICLR - MarketBeat
ICON plc Releases Findings from Two Biotech Sector Survey - marketscreener.com
Here’s How ICON plc (ICLR) Recovered from Challenges - Insider Monkey
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive - Business Wire
Icon Plc $ICLR Shares Sold by M&T Bank Corp - MarketBeat
Fayez Sarofim & Co Has $13.72 Million Holdings in Icon Plc $ICLR - MarketBeat
Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating - 富途牛牛
Kennedy Capital Management LLC Sells 10,424 Shares of Icon Plc $ICLR - MarketBeat
Brant Point Investment Management LLC Sells 7,000 Shares of Icon Plc $ICLR - MarketBeat
Brown Advisory Inc. Buys 17,717 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Acquired by Jump Financial LLC - MarketBeat
Invesco Ltd. Increases Position in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Sold by Quantbot Technologies LP - MarketBeat
BMO Capital reiterates Market Perform rating on ICON stock with $175 target - Investing.com UK
What ICON (ICLR)'s Trial Site Bottleneck Survey Reveals About Its Evolving CRO Partnership Strategy - simplywall.st
New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup - Applied Clinical Trials
14,202 Shares in Icon Plc $ICLR Bought by Taikang Asset Management Hong Kong Co Ltd - MarketBeat
1,090,679 Shares in Icon Plc $ICLR Purchased by Norges Bank - MarketBeat
Distillate Capital Partners LLC Sells 10,245 Shares of Icon Plc $ICLR - MarketBeat
Brandes Investment Partners LP Purchases Shares of 207,533 Icon Plc $ICLR - MarketBeat
1832 Asset Management L.P. Boosts Stock Position in Icon Plc $ICLR - MarketBeat
Iqvia, Icon, Fortrea downgraded at Barclays on tariff overhang - MSN
Free cash flow per share of ICON Plc – TRADEGATE:IJF - TradingView
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Si - PharmiWeb.com
Icon plc Announces Results of Its Latest Industry Survey - marketscreener.com
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions - Business Wire
River Road Asset Management LLC Invests $30.41 Million in Icon Plc $ICLR - MarketBeat
Icon Energy Corp. (ICON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Legacy Capital Wealth Partners LLC Acquires 2,296 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc (ICLR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):